Home - AnaptysBio
AnaptysBio is a clinical-stage antibody development company advancing therapeutic antibody product candidates focused on unmet medical needs in inflammation.
About - AnaptysBio
AnaptysBio, Inc. 10770 Wateridge Circle Suite 210 San Diego, CA 92121-5801 . Phone: (858) 362-6295 [email protected]
Pipeline - AnaptysBio
AnaptysBio, Inc. 10770 Wateridge Circle Suite 210 San Diego, CA 92121-5801 (858) 362-6295 (ph) [email protected]
Overview - AnaptysBio
Rosnilimab is a novel PD-1 agonist that reduces overactive T cell inflammation. It has two distinct mechanisms of action, depletion and agonism, prevalent both in inflamed tissue and the …
Science - AnaptysBio
Immune cell modulators are a novel therapeutic class with the potential to deliver differentiated outcomes in autoimmune and inflammatory diseases including dermatology, gastroenterology, …
News - AnaptysBio, Inc.
SAN DIEGO , Jan. 07, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology …
Working Together to Transform Patient Health - AnaptysBio
We never conduct our interview process via messaging apps, freelance sites or social media platforms (i.e., Google Hangouts, WhatsApp, Signal, etc.). We only communicate with …
Anaptys Announces Pricing of $100 Million ... - AnaptysBio, Inc.
SAN DIEGO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology …
Vanda Pharmaceuticals and Anaptys Announce Exclusive Global …
Feb 3, 2025 · WASHINGTON and SAN DIEGO, Feb. 3, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) and AnaptysBio, Inc. (Anaptys) (Nasdaq: …
Anaptys to Present at the Guggenheim SMID Cap Biotech …
SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, …